Witnessing the stock’s movement on the chart, on Wednesday Dynavax Technologies Corp. (NASDAQ: DVAX) had a quiet start as it plunged -2.89% to $11.42, before settling in for the price of $11.76 at the close. Taking a more long-term approach, DVAX posted a 52-week range of $10.06-$15.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 239.63%. Meanwhile, its Annual Earning per share during the time was 54.52%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 607.60%. This publicly-traded company’s shares outstanding now amounts to $130.62 million, simultaneously with a float of $130.21 million. The organization now has a market capitalization sitting at $1.49 billion. At the time of writing, stock’s 50-day Moving Average stood at $12.28, while the 200-day Moving Average is $13.53.
Dynavax Technologies Corp. (DVAX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Drug Manufacturers – Specialty & Generic industry. Dynavax Technologies Corp.’s current insider ownership accounts for 0.31%, in contrast to 96.92% institutional ownership. According to the most recent insider trade that took place on Mar 01 ’24, this organization’s Chief Accounting Officer sold 20,526 shares at the rate of 12.78, making the entire transaction reach 262,322 in total value, affecting insider ownership by 0. Preceding that transaction, on Jan 04 ’24, Company’s SVP and CMO sold 1,500 for 15.00, making the whole transaction’s value amount to 22,500. This particular insider is now the holder of 49,925 in total.
Dynavax Technologies Corp. (DVAX) Earnings and Revenue Records
Dynavax Technologies Corp.’s EPS increase for this current 12-month fiscal period is 607.60% and is forecasted to reach 0.44 in the upcoming year.
Dynavax Technologies Corp. (NASDAQ: DVAX) Trading Performance Indicators
Let’s observe the current performance indicators for Dynavax Technologies Corp. (DVAX). It’s Quick Ratio in the last reported quarter now stands at 12.96. The Stock has managed to achieve an average true range (ATR) of 0.31. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.42. Similarly, its price to free cash flow for trailing twelve months is now 15.46.
In the same vein, DVAX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.07, a figure that is expected to reach -0.02 in the next quarter, and analysts are predicting that it will be 0.44 at the market close of one year from today.
Technical Analysis of Dynavax Technologies Corp. (DVAX)
Going through the that latest performance of [Dynavax Technologies Corp., DVAX]. Its last 5-days volume of 3.39 million indicated improvement to the volume of 2.04 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 51.75% While, its Average True Range was 0.32.
Raw Stochastic average of Dynavax Technologies Corp. (DVAX) in the period of the previous 100 days is set at 5.53%, which indicates a major fall in contrast to 21.88% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 23.48% that was lower than 26.96% volatility it exhibited in the past 100-days period.
